News
3h
MarketBeat on MSNTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyThis week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.
Ali Eastburn was looking forward to her son's wedding when her side-effects from weight loss drugs went from bad to worse ...
17h
TipRanks on MSNHow Wall Street Missed the Bigger Picture on Novo Nordisk Stock (NVO)Once seemingly unstoppable, Novo Nordisk ($NVO) stock is now caught in a storm. Fierce competition in the GLP-1 ...
A man who says he got 'Ozempic penis' from the weight loss drug Wegovy has opened up on how his sex life has been going ...
Flush with Trump connections, Ballard Partners is D.C.’s new lobbying powerhouse — and its clients are reaping the benefits.
Novo Nordisk remains the GLP-1 leader with over 65% market share. Read an in-depth BVO stock analysis and why we rate it as a ...
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results